PAVmed Inc. Reports Unregistered Equity Sales

Ticker: PAVM · Form: 8-K · Filed: Feb 21, 2025 · CIK: 1624326

Sentiment: neutral

Topics: equity-sale, warrants, capital-raising

Related Tickers: PAVM

TL;DR

PAVM issued new warrants on Feb 18, 2025. Dilution alert!

AI Summary

On February 18, 2025, PAVmed Inc. filed an 8-K report detailing unregistered sales of equity securities. The filing indicates the issuance of Series Z Warrants to Purchase Common Stock, with a par value of $0.001 per share. This event is part of the company's ongoing financial activities and capital raising efforts.

Why It Matters

This filing indicates PAVmed Inc. has issued new warrants, which could impact existing shareholders through potential dilution and signal the company's need for capital.

Risk Assessment

Risk Level: medium — The issuance of unregistered equity securities, such as warrants, can lead to dilution for existing shareholders and may indicate the company is raising capital under specific terms.

Key Numbers

Key Players & Entities

FAQ

What is the total number of Series Z Warrants issued?

The filing does not specify the total number of Series Z Warrants issued, only their par value.

What is the exercise price of the Series Z Warrants?

The filing does not disclose the exercise price of the Series Z Warrants.

Who are the purchasers of these unregistered equity securities?

The filing does not identify the specific purchasers of the Series Z Warrants.

What is the intended use of the capital raised from the sale of these warrants?

The filing does not detail the intended use of any capital raised from the warrant issuance.

Are these warrants convertible into common stock?

Yes, the filing states they are 'Series Z Warrants to Purchase Common Stock'.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on February 21, 2025 regarding PAVmed Inc. (PAVM).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing